brequinar has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Z; Deng, X; Dong, L; Fathi, AT; Gao, L; Gao, M; Han, L; Horne, D; Huang, H; Huang, Y; Kulkarni, P; Li, C; Li, H; Li, L; Li, W; Li, Y; Li, Z; Marcucci, G; Mulloy, JC; Müschen, M; Olsen, MJ; Prince, E; Qin, H; Qin, X; Qing, Y; Robinson, S; Salgia, R; Shen, C; Su, R; Sun, J; Tan, B; Wei, M; Weng, H; Wu, X; Wunderlich, M; Xie, J; Zhang, B; Zhao, Z | 1 |
| Cleaveland, ES; Cooney, DA; Ford, H; Kelley, JA; Paull, K; Zaharevitz, DW | 1 |
2 other study(ies) available for brequinar and Leukemia
| Article | Year |
|---|---|
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Anthracenes; Biphenyl Compounds; Cell Line, Tumor; Cell Self Renewal; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Immune Evasion; Leukemia; Membrane Glycoproteins; Molecular Structure; Protein Binding; Protein Domains; Receptors, Immunologic; U937 Cells | 2020 |
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colonic Neoplasms; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Female; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lung Neoplasms; Male; Melanoma; Mitochondria; Orotic Acid; Ovarian Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Prostatic Neoplasms; Ribonucleotides; Sodium Bicarbonate; Software; Tumor Cells, Cultured | 1996 |